МЕТОДЫ ОЦЕНКИ ВИСЦЕРАЛЬНОГО ОЖИРЕНИЯ В КЛИНИЧЕСКОЙ ПРАКТИКЕ
https://doi.org/10.15829/1560-4071-2016-4-89-96
Аннотация
Ожирение, прежде всего висцеральное, является хроническим заболеванием с высоким риском кардиометаболических осложнений. Точная диагностика висцерального ожирения (ВО) является непростой задачей, так как большинство методов имеют как достоинства, так и ограничения для их использования. В статье рассматриваются возможности и недостатки антропометрических, ультразвуковых методов, а также магниторезонансной и компьютерной томографии. Предлагается шире использовать наиболее простой и доступный метод прямой диагностики ВО методом эхокардиографии по степени эпикардиального ожирения.
Об авторах
Г. А. Чумакова
ГБОУ ВПО Алтайский государственный медицинский университет Минздрава
России;
НИИ комплексных проблем сердечно-сосудистых заболеваний
Россия
Конфликт интересов:
Россия
д.м.н., профессор кафедры госпитальной и поликлинической терапии, Барнаул;
в.н.с., Кемерово
Конфликт интересов:
Конфликта интересов нет
Н. Г. Веселовская
КГБУЗ Алтайский краевой кардиологический диспансер;
НИИ комплексных проблем сердечно-сосудистых заболеваний
Россия
Конфликт интересов:
Россия
с.н.с., Барнаул;
д.м.н., зав. кардиологическим отделением, Кемерово
Конфликт интересов:
Конфликта интересов нет
Список литературы
1. American Association of Clinical Endocrinologists и American college of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract 2014; 20(9): 978-989
2. Guo F, Moellering DR, Garvey WT. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity (Silver Spring) 2014; 22: 110-118.
3. Druzhilov MA, Druzhilova OYu, Beteleva YuE, Kuznetsova TYu. Obesity as a cardiovascular risk factor: accent on quality and functional activity of adipose tissue. Russ J Cardiol 2015; 4(120): 111–117. Russian (Дружилов М.А., Дружилова О.Ю., Бетелева Ю.Е., Кузнецова Т.Ю. Ожирение как фактор сердечно-сосудистого риска: акцент на качество и функциональную активность жировой ткани. Российский кардиологический журнал 2015; 4(120): 111–117).
4. Gonzalez-Campoy JM, St. Jeor S, Castorino K, et al. Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults: Cosponsored by the American Association of Clinical Endocrinologists/The American College of Endocrinology and the Obesity Society. Endocr Pract 2013; 19: 1-82.
5. Bessesen, D.H. Evaluation and management of obesity Hanley and Belfus Inc. Philadelphia 2006; 24.
6. Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention, NAASO, The Obesity Society, the American Society for Nutrition and the American Diabetes Association. Am J Clin Nutr 2007; 85(5): 1197-1202.
7. Druzhilov MA, Beteleva YuE, Kuznetsova TYu. Epicardial adipose tissue thickness – an alternative to waist circumference as a stand-alone or secondary main criterion in metabolic syndrome diagnostics? Russ J Cardiol 2014; 3(107):76–81. Russian (М.А. Дружилов, Ю.Е. Бетелева, Т.Ю. Кузнецова. Толщина эпикардиального жира – альтернатива окружности талии как самостоятельный или второй основной критерий для диагностики метаболического синдрома? Российский кардиологический журнал 2014; 3(107): 76–81).
8. National Institutes of Health (NIH). Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report. Washington, D.C: Government Printing Office 1998; 47
9. Madeira FB, Silva AA, Veloso HF, et al. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS One 2013; 8: e60673.
10. Koning L, Merchant AT, Pogue J. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007;7(28):850-6.
11. Coutinho T, Goel K, Corrêa De Sá D, et al. Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: Role of "normal weight central obesity". J Am Coll Cardiol 2013; 61: 553-560
12. O'Neill T, Guaraldi G, Orlando G. Combined Use of Waist and Hip Circumference to Identify Abdominally Obese HIV-Infected Patients at Increased Health Risk. PLoS One 2013; 5(8): 625-38.
13. Öhman MK, Luo W. Perivascular Visceral Adipose Tissue Induces Atherosclerosis in Apolipoprotein E Deficient. Atherosclerosis 2011 Nov; 219(1): 33–39
14. Scherzer R, Shen W, Heymsfield SB. Obesity (Silver Spring) 2011 Feb; 19(2): 283–291.
15. Fluchter S, Haghi D, Dinter D, et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity 2007; 15: 870–878.
16. Kuk JL, Church TS, Blair SN. Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome? Diabetes Care 2006; 29: 679 - 684.
17. Schlett CL, Massaro JM, Lehman SJ, et al. Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes 2009; 33: 226-232.
18. Fox CS, Massaro JM, Schlett CL, et al. Peri-aortic fat deposition is associated with peripheral arterial disease: the Framingham Heart Study. Circ Cardiovasc Imaging 2010; 3: 515-519.
19. Reisin E, Jack AV. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am 2009; 93: 733–751.
20. Sijens PE, Edens MA, Bakker SJ, Stolk RP. MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol 2010; 16: 1993-1998.
21. Kelley DE, Slasky BS, Janosky J. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. American Journal of Clinical Nutrition 1991; 54(3): 509-515.
22. Karampinos DC, Baum T, Nardo L, et al. Characterization of the regional distribution of skeletal muscle adipose tissue in type 2 diabetes using chemical shift-based water/fat separation. Journal of Magnetic Resonance Imaging 2012; 35(4): 899-907.
23. Wattjes MP, Kley RA, Fischer D. Neuromuscular imaging in inherited muscle diseases. European Radiology. 2010; 20(10): 2447-2460.
24. Chen CL, Cheng YF, Yu CY, et al. Wang CC, Wang SH, et al. Living donor liver transplantation: the Asian perspective. Transplantation 2014; 97 Suppl 8:S3
25. Karampinos DC, Baum T, Nardo L, et al. Characterization of the regional distribution of skeletal muscle adipose tissue in type 2 diabetes using chemical shift-based water/fat separation. Journal of Magnetic Resonance Imaging 2012; 35(4): 899-907.
26. Wattjes MP, Kley RA, Fischer D. Neuromuscular imaging in inherited muscle diseases. European Radiology 2010; 20(10): 2447-2460
27. Browning J.D. Common genetic variants and nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol 2013;11:1191-1193.
28. World Gastroenterology Organisation Global Guidelines: Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis 2012 [accessed on 17 June 2015]. Online Report. Availableonline:http://www.worldgastroenterology.org/assets/export/userfiles/2012_NASH%20and%20NAFLD_Final_long.pdf
29. Dey D, Nakazato R, Li D. Epicardial and thoracic fat - Noninvasive measurement and clinical implications. Cardiovasc Diagn Ther 2012 Jun; 2(2): 85-93.
30. Bastarrika G, Broncano J, Schoepf UJ, et al. Relationship between coronary artery disease and epicardial adipose tissue quantification at cardiac CT: comparison between automatic volumetric measurement and manual bidimensional estimation. Acad Radiol 2010; 17:727-34
31. Dagvasumberel M., Shimabukuro M., Nishiuchi T. Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in Japanese subjects. Cardiovasc Diabetol 2012; 11: 106-110.
32. Gorter PM, Lindert AS, Vos AM, et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008; 197: 896-903.
33. Flüchter S, Lindert AS, Vos AM, et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity 2007;15:870-878.
34. Wang TD, Lee WJ, Shih FY, et al. Association of epicardial adipose tissue with coronary atherosclerosis is region-specific and independent of conventional risk factors and intra-abdominal adiposity. Atherosclerosis 2010; 213: 279–287.
35. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304-10.
36. Bertaso AG, Bertol D, Duncan DD. Epicardial Fat: Definition, Measurements and Systematic Review of Main Outcomes. Arq Bras Cardiol 2013; 101(1): 18–28.
37. Jeong JW, Jeong MH, Yun KH, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 4(71): 536–9.
38. Eroglu S, Sade LE, Yildirir A, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009; 3(19): 211-7.
39. Mookadam F, Goel R, Alharthi MS. Epicardial Fat and Its Association with Cardiovascular Risk: A Cross-Sectional Observational Study. Heart Views 2010; 3(11): 103-108.
40. Pierdomenico SD, Pierdomenico AM. Epicardial Adipose Tissue and Metabolic Syndrome in Hypertensive Patients With Normal Body Weight and Waist Circumference. Am J Hypertens 2011; 24: 1245-1249.
41. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009; 22: 1311-9.
42. Mustelie JV, Rego JO, Gonzales AG, et al. Echocardiographic parameters of epicardial fat deposition and its relation to coronary artery disease . Arq Bras Cardiol 2011; 2(97): 122-129.
43. Chumakova GA, Veselovskaya NG, Kozarenko AA, et al. Epicardial adipose depot: morphology, diagnostics, clinical value. Serdtze 2011; 10(3): 143–147. Russian (Чумакова Г.А., Веселовская Н.Г., Козаренко А.А. и др. Эпикардиальное жировое депо: морфология, диагностика, клиническое значение. Сердце 2011; 3: 143-147).
44. Kim HM, Kim KJ, Lee HJ et al. Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance. Cardiovasc Diabetol 2012; 11: 83-86.
45. Iacobellis G, Sharma AM. Adiposity of the heart. Ann Intern Med 2006; 145: 554-555.
46. Granér M, Siren R, Nyman K et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J Clin Endocrinol Metab 2013; 3(98): 1189-97.
47. Malavazos AE, Di Leo G, Secchi F. Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 2010; 105(12): 1831-5.
48. Chumakova GA, Veselovskaya NG, Gritzenko OV, et al. Epicardial fat as a possible marker of the metabolic syndrome. Kardiosomatika 2012; 4: 38-43. Russian (Чумакова Г.А., Веселовская Н.Г., Гриценко О.В. и др. Эпикардиальное ожирение как возможный маркер метаболического синдрома. Кардиосоматика 2012; 4: 38-43).
49. Nikaeen, F. The association between epicardial fat thickness in echocardiography and coronary restenosis in drug eluting stents ARYA. Atheroscler 2011; 1(7): 11–17.
50. Greif M, Becker A, Ziegler F, et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis . Arterioscler Thromb Vasc Biol 2009; 5(29): 781–786.
Рецензия
Для цитирования:
Чумакова Г.А., Веселовская Н.Г. МЕТОДЫ ОЦЕНКИ ВИСЦЕРАЛЬНОГО ОЖИРЕНИЯ В КЛИНИЧЕСКОЙ ПРАКТИКЕ. Российский кардиологический журнал. 2016;(4):89-96. https://doi.org/10.15829/1560-4071-2016-4-89-96
For citation:
Chumakova G.A., Veselovskaya N.G. METHODS OF VISCERAL OBESITY ASSESSMENT IN CLINICAL PRACTICE. Russian Journal of Cardiology. 2016;(4):89-96. (In Russ.) https://doi.org/10.15829/1560-4071-2016-4-89-96
Просмотров:
951
Послать статью по эл. почте 